Untying the Gordian knot of composite hemangioendothelioma: Discovery of novel fusions
Genes, Chromosomes and Cancer · 2024-01 · 63 (1)
DOI: 10.1002/gcc.23198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, Chromosomes and Cancer, online erschienen am 02.09.2023. Verfasst von Konstantinos Linos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Hemangioendothelioma, Hemangioendothelioma, Epithelioid, Hemangioma. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Composite hemangioendothelioma is a rare, locally aggressive, and rarely metastasizing vascular neoplasm which affects both children and adults. Recently, a number of gene fusions including YAP1::MAML2 , PTBP1::MAML2 , and EPC1::PHC2 have been detected in a small subset of cases with or without neuroendocrine expression. Herein, we present four additional cases with novel in‐frame fusions. The cohort comprises two females and two males with a wide age range at diagnosis (24–80 years). Two tumors were deep involving the right brachial plexus and mediastinum, while the remaining were superficial (right plantar foot and abdominal wall). The size ranged from 1.5 to 4.8 cm in greatest dimension. Morphologically, all tumors had an admixture of at least two architectural patterns including retiform hemangioendothelioma, hemangioma, epithelioid hemangioendothelioma, or angiosarcoma. The tumors were positive for endothelial markers CD31 (3/3), ERG (4/4), and D2‐40 (1/4, focal), while SMA was expressed in 2/3 highlighting the surrounding pericytes. Synaptophysin showed immunoreactivity in 2/3 cases. One patient had a local recurrence after 40 months, while two patients had no evidence of disease 4 months post‐resection. Targeted RNA sequencing detected novel in‐frame fusions in each of the cases: HSPG2::FGFR1, YAP1::FOXR1, ACTB::MAML2 , and ARID1B::MAML2 . The two cases with neuroendocrine expression occurred as superficial lesions and harbored YAP1::FOXR1 and ARID1B::MAML2 fusions. Our study expands on the molecular spectrum of this enigmatic tumor, further enhancing our current understanding of the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Department of Pathology, Cleveland Clinic, Cleveland, Ohio, USA.
- Institute of Pathology, Friedrich-Alexander-University Erlangen-Nurnberg, University Hospital, Erlangen, Germany.
ORCID-Profile: Konstantinos Linos, Josephine K Dermawan, Narasimhan P Agaram, Abbas Agaimy, Cristina R Antonescu
Förderung
- NCI NIH HHS
Zitieren
APA
Linos, K., Dermawan, J. K., Pulitzer, M., Hameed, M., Agaram, N. P., Agaimy, A., & Antonescu, C. R. (2024). Untying the Gordian knot of composite hemangioendothelioma: Discovery of novel fusions. Genes, Chromosomes and Cancer, 63(1). https://doi.org/10.1002/gcc.23198
Vancouver
Linos K, Dermawan JK, Pulitzer M, Hameed M, Agaram NP, Agaimy A, et al. Untying the Gordian knot of composite hemangioendothelioma: Discovery of novel fusions. Genes, Chromosomes and Cancer. 2024;63(1). doi:10.1002/gcc.23198
BibTeX
@article{Linos2024,
author = {Linos, Konstantinos and Dermawan, Josephine K and Pulitzer, Melissa and Hameed, Meera and Agaram, Narasimhan P and Agaimy, Abbas and Antonescu, Cristina R},
title = {Untying the Gordian knot of composite hemangioendothelioma: Discovery of novel fusions},
journal = {Genes, Chromosomes and Cancer},
year = {2024},
volume = {63},
number = {1},
doi = {10.1002/gcc.23198}
}
EUVIMED